Published: Tue, September 19, 2017
Finance | By Loren Pratt

Walgreens Boots Alliance, Inc. (WBA) - Active Stock Review

Walgreens Boots Alliance, Inc. (WBA) - Active Stock Review

MCF Advisors LLC increased its position in Walgreens Boots Alliance by 68.2% during the 1st quarter. Among active positions in the latest quarter, 584 holders increased their positions by a total of 43.65 million shares, 597 holders decreased the positions by a total of 53.87 million shares, and 207 holders held their positions. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator's stock worth $2,727,932,000 after acquiring an additional 1,824,300 shares during the period. State Street Corp raised its position in Walgreens Boots Alliance by 1.8% in the first quarter.

Array BioPharma Inc. (ARRY) is recuperating from the fall at $3.45, the 52-week low.

Walgreens Boots Alliance, Inc. has been given an analysts' mean target of 93.05. Following the completion of the purchase, the director now directly owns 600 shares of the company's stock, valued at approximately $48,408. Institutional investors and hedge funds own 60.16% of the company's stock.

COPYRIGHT VIOLATION NOTICE: "Tokio Marine Asset Management Co". If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and worldwide copyright & trademark law.

Walgreens stock, meanwhile, was up 2% Tuesday before open.

A number of research firms recently weighed in on WBA. The company P/S (price to Sales) ratio is 0.75, P/B (price to Book) ratio is 2.9, while its P/C (price to Cash) ratio stands at 7.16. BidaskClub downgraded shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating in a research report on Tuesday, September 12th. Analysts set a 12-month price target of $35.75 a share. Loop Capital initiated coverage on Walgreens Boots Alliance in a report on Thursday, August 24th. They issued a "buy" rating and a $95.00 price objective on the stock.

In the most updated research from a number of analysts on Wall Street, the company gets 19 Buys and 0 Sell among 25 analysts. Using what are known as momentum indicators, we can use the stock's price momentum to get a sense of whether the stock is in the midst of, or nearing the end of, a current trend. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The percentage of shares being held by the company management was 0.3% while institutional stake was 0%. If the published price targets set by Walgreens Boots Alliance, Inc. analysts have any power to influence the stock's share price, the highest price target set for WBA is $100. (WBA) opened at 82.60 on Tuesday.


ILLEGAL ACTIVITY WARNING: "Walgreens Boots Alliance, Inc". The company has a market cap of $88.39 billion, a P/E ratio of 20.86 and a beta of 1.26. Its sales stood at 21.90% a year on average in the period of last five years.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 29th. The firm had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The business's revenue was down 1.8% on a year-over-year basis. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.30 by $0.03.

Due to the expected timing of store purchases under the amended agreement, Walgreens Boots Alliance doesn't expect the transaction to have a significant impact on its adjusted diluted net earnings per share in the fiscal year ending August 31, 2018.

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. This represents a $1.60 annualized dividend and a yield of 1.92%. The ex-dividend date was Wednesday, August 16th. Tarbox Group Inc. increased its position in Walgreens Boots Alliance by 288.3% during the 1st quarter.

Walgreens Boots Alliance announced that its Board of Directors has authorized a stock buyback program on Thursday, June 29th that permits the company to buyback $5.00 billion in shares. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale.

The company's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as increasingly global health and beauty product brands such as No7, Botanics, Liz Earle and Soap & Glory.

Like this: